[ORGANIZATION]
PROTECT trial
Featured in 1 tracked story · first seen
Also covered in
-
Travere Therapeutics reports sparsentan reduces biomarkers in IgA nephropathy
[HEALTH] · 3 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[HEALTH] · 3 sources ·